A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors
Clinical trial NCT06235541 · WITHDRAWN
Trial details
- NCT number
- NCT06235541
- Sponsor
- Genome & Company
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2026-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.